Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1,F2	Oct 4, 2016	C	1,043,510	—	A	1,126,670	D
Common Stock^F1,F2	Oct 4, 2016	C	668,353	—	A	1,795,023	D
Common Stock^F1,F2	Oct 4, 2016	C	119,055	—	A	1,914,078	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Series A Preferred Stock^F1,F2,F3	—	Oct 4, 2016	C	2,024,410	D	—	—	Common Stock	1,043,510	D
Series A-1 Preferred Stock^F1,F2,F3	—	Oct 4, 2016	C	1,296,605	D	—	—	Common Stock	668,353	D
Series B Preferred Stock^F1,F2,F3	—	Oct 4, 2016	C	230,968	D	—	—	Common Stock	119,055	D

Explanation of responses

F1Originate Growth Fund #1Q, L.P. ("Originate #1Q") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering.
F2This report is filed jointly by Originate #1Q, Originate Growth GP, LLC ("Originate GP"), Glen Bressner ("Bressner"), Eric Arnson ("Arnson"), and Michael Gausling ("Gausling"). The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.
F3All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.